As the global pandemic has created a greater need for remote monitoring, the adoption of machine learning and artificial intelligence (AI) into clinical trials can help to generate new efficiencies to enhancing patient safety and trial outcomes, while not replacing the need for clinical trial monitors or other research personnel. This Byline explores the links between machine learning and AI as both are becoming more widely adopted in the clinical trials sphere…